Category Archives: Pricing

Pharma PSUs Are Not Ready To Die!

By Murali Neelakantan, BloombergQuintOpinion | February 7, 2017 The government’s decision to explore the strategic sale of Indian Drugs and Pharmaceuticals Ltd. and Bengal Chemicals – even as questions were asked of the move last week by parliamentarians including those from the BJP … Continue reading

Posted in Generics, Patent, Pricing, Uncategorized | Leave a comment

Health groups decry Government moves to undermine affordable access to medicines

Right to life and health of patients compromised in the name of “ease of doing business” 8 November 2016, New Delhi – Health groups are raising grave concerns over recent reports that the Government, through discussions with the Niti Ayog, … Continue reading

Posted in Drug prices, Pricing, Uncategorized | Tagged , | Leave a comment

Epipen Price Gouging

People in the US continue to battle with high drug prices and the recent controversy around Epipen (Epinephrine injections) is another example that has drawn attention to the escalating drug prices. Anaphylaxis is a serious life-threatening allergic reaction, which in … Continue reading

Posted in Drug prices, Price hikes, Uncategorized | Leave a comment

Cancer drug prices are high at launch and stay that way

By ED SILVERMAN @Pharmalot, Stat News | May 2, 2016 The cost of new oral cancer medicines is rising no matter how you slice it. Between 2007 and 2013, these pills increased in cost 5 percent each year, and rose … Continue reading

Posted in Drug prices, Pricing, Uncategorized | Leave a comment

France gets G7 to discuss global regulation of medicine prices

By Matthias Blamont & Jean- Baptiste Vey, Reuters | May 3, 2016 France will press its G7 partners this month to launch an “irreversible” process to control the prices of new medicines, part of a global drive to make life-saving … Continue reading

Posted in Price hikes, Pricing, Uncategorized | Leave a comment

Canadian pharma group raises price of NHS eye drug 14-fold

By Dan McCrum in London and David Crow, Financial Times, New York| May 1, 2016 The National Health Service has been stung by a Canadian drugs group that has heavily increased the prices of some generic medicines in a move … Continue reading

Posted in Price hikes, Uncategorized | Leave a comment

Petition by civil society to President Hollande on exorbitant prices of cancer drugs & demands transparency in pricing of innovative drugs

To fight the soaring prices of cancer medicines globally, French Cancer League last week initiated a petition to reiterates the following issues: Prices of cancer treatments are “unjustified, illegitimate, unacceptable & unsustainable” for the French public health system Medicines should … Continue reading

Posted in Innovation, Petitions, Price hikes, Transparency, Uncategorized | Leave a comment